Hypertension associated polymorphisms in WNK1/WNK4 are not associated with hydrochlorothiazide response

Clinical Biochemistry

Volumn 44, Issue 13, 2011, Pages 1045-1049

  Han, Yunfeng ^a,b   Fan, XiaoHan ^b   Sun, Kai ^b   Wang, Xiaojian ^b   Wang, Yibo ^b   Chen, Jingzhou ^b   Zhen, Yisong ^b   Zhang, Weili ^b   Hui, Rutai ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Blood pressure response; Hydrochlorothiazide; Hypertension; Polymorphisms; WNK

Indexed keywords

HYDROCHLOROTHIAZIDE; POTASSIUM; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; DRUG RESPONSE; FEMALE; GENETIC RISK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHARMACOGENOMICS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHINA; DIURETICS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 80051674618     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.06.008     Document Type: Article

References (39)

1. Cadman P.E., O'Connor D.T. Pharmacogenomics of hypertension. Curr Opin Nephrol Hypertens 2003, 12:61-70.
2. Marteau J.B., Zaiou M., Siest G., Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens 2005, 23:2127-2143.
3. The ALLHAT Officers and Coordinators for ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA 2002, 288:2981-2997.
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA 2003, 289:2560-2572.
5. Velázquez H., Wright F.S. Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule. Am J Physiol 1986, 250:F1013-F1023.
6. Wilson F.H., Kahle K.T., Sabath E., Lalioti M.D., Rapson A.K., Hoover R.S., et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003, 100:680-684.
7. Yang C.L., Angell J., Mitchell R., Ellison D.H. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003, 111:1039-1045.
8. Rinehart J., Kahle K.T., de Los Heros P., Vazquez N., Meade P., Wilson F.H., et al. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis. Proc Natl Acad Sci USA 2005, 102:16777-16782.
9. Yang C.-L., Zhu X., Ellison D.H. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007, 117:3403-3411.
10. Wilson F.H., Disse-Nicodeme S., Choate K.A., Ishikawa K., Nelson-Williams C., Desitter I., et al. Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112.
11. Zambrowicz B.P., Abuin A., Ramirez-Solis R., Richter L.J., Piggott J., BeltrandelRio H., et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003, 100:14109-14114.
12. Newhouse S.J., Wallace C., Dobson R., Mein C., Pembroke J., Farrall M., et al. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension (BRIGHT) study. Hum Mol Genet 2005, 14:1805-1814.
13. Erlich P.M., Cui J., Chazaro I., Farrer L.A., Baldwin C.T., Gavras H., et al. Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension 2003, 41:1191-1195.
14. Kokubo Y., Kamide K., Inamoto N., Tanaka C., Banno M., Takiuchi S., et al. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet 2004, 49:507-515.
15. Tobin M.D., Raleigh S.M., Newhouse S., Braund P., Bodycote C., Ogleby J., et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005, 112:3423-3429.
16. Sun Z.J., Li Y., Lu J.Y., Ding Q., Liang Y., Shi J.P., et al. Association of Ala589Ser polymorphism of WNK4 gene with essential hypertension in a high-risk Chinese population. J Physiol Sci 2009, 59:81-86.
17. Speirs H.J., Morris B.J. WNK4 intron 10 polymorphism is not associated with hypertension. Hypertension 2004, 43:766-768.
18. Turner S.T., Schwartz G.L., Chapman A.B., Boerwinkle E. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 2005, 46:758-765.
19. Manunta P., Lavery G., Lanzani C., Braund P.S., Simonini M., Bodycote C., et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008, 52:366-372.
20. Han Y.F., Fan X.H., Wang X.J., Sun K., Xue H., Li W.J., et al. Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide. Am J Hypertens 2010, 24:340-346.
21. Conde L., Vaquerizas J.M., Dopazo H., Arbiza L., Reumers J., Rousseau F., et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 2006, 34:W621-W625.
22. Sutton-Tyrrell K., Bostom A., Selhub J., Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 1997, 96:1745-1749.
23. Oda E., Kawai R. High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women. Br J Biomed Sci 2011, 68:29-33.
24. Xu B.E., Stippec S., Chu P.Y., Lazrak A., Li X.J., Lee B.H., et al. WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 2005, 102:10315-10320.
25. Ring A.M., Cheng S.X., Leng Q., Kahle K.T., Rinehart J., Lalioti M.D., et al. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo. Proc Natl Acad Sci USA 2007, 104:4020-4024.
26. Baima J., Nicolaou M., Schwartz F., DeStefano A.L., Manolis A., Gavras I., et al. Evidence for linkage between essential hypertension in humans and a putative locus on chromosome 17 in Caucasians. Hypertension 1999, 34:4-7.
27. Levy D., DeStefano A.L., Larson M.G., O'Donnell C.J., Lifton R.P., Gavras H., et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000, 36:477-483.
28. Lalioti M.D., Zhang J., Volkman H.M., Kahle K.T., Hoffmann K.E., Toka H.R., et al. WNK4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006, 38:1124-1132.
29. Yang S.S., Morimoto T., Rai T., Chiga M., Sohara E., Ohno M., et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a WNK4(D561A/+) knockin mouse model. Cell Metab 2007, 5:331-344.
30. Subramanya A.R., Yang C.L., McCormick J.A., Ellison D.H. WNK kinases regulate sodium chloride and potassium transport by the aldosteronesensitive distal nephron. Kidney Int 2006, 70:630-634.
31. Huang C.L., Yang S.S., Lin S.H. Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 2008, 17:519-525.
32. Delaloy C., Lu J., Houot A.M., Disse-Nicodeme S., Gasc J.M., Corvol P., et al. Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 2003, 23:9208-9221.
33. Lu M., Wang X., Wang F., Wang S., Lin R., Wang S., et al. WNK4 polymorphisms and essential hypertension in the Uyghur population. Clin Exp Hypertens 2009, 31:179-185.
34. Kamide K., Takiuchi S., Tanaka C., Miwa Y., Yoshii M., Horio T., et al. Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes. Am J Hypertens 2004, 17:446-449.
35. Blencowe B.J. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 2000, 25:106-110.
36. Carlini D.B., Genut J.E. Synonymous SNPs provide evidence for selective constraint on human exonic splicing enhancers. J Mol Evol 2006, 62:89-98.
37. Kahle K.T., Rinehart J., Giebisch G., Gamba G., Hebert S.C., Lifton R.P. A novel protein kinase signaling pathway essential for blood pressure regulation in humans. Trends Endocrinol Metab 2008, 19:91-95.
38. Tobin M.D., Timpson N.J., Wain L.V., Ring S., Jones L.R., Emmett P.M., et al. Common variation in the WNK1 gene and blood pressure in childhood: the Avon Longitudinal Study of Parents and Children. Hypertension 2008, 52:974-979.
39. Newhouse S., Farrall M., Wallace C., Hoti M., Burke B., Howard P., et al. Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion. PLoS One 2009, 4:e5003.